Advaxis, Inc., the live, attenuated Listeria monocytogenes (Lm) immunotherapy company, has updated the survival information from its phase 1 trial of ADXS11-001 which assessed the safety of this agent in advanced, metastatic, progressive cervix cancer in women whose disease progressed subsequent to treatment with cytotoxic therapy.
-
29Jul
-
28Jul
The more you know about COPD, the better you can manage it. Find out about treatments for chronic obstructive pulmonary disease.
Tags: Treatment
-
28Jul
Hospira, Inc. (NYSE: HSP), the world leader in generic injectable pharmaceuticals, announced the start of a U.S. Phase I clinical trial of its biosimilar erythropoietin (EPO) in patients with renal (kidney) dysfunction who have anemia, an important step on the road toward introducing a biosimilar product in the United States. Erythropoietin is a treatment for anemia associated with chronic renal failure and chemotherapy…
-
28Jul
WebMD looks at a sensitive topic for breast cancer patients: sex and intimacy. Discover ways you can keep intimacy alive even though you’re dealing with breast cancer and its treatment.
Tags: Breast Cancer, Cancer, Treatment
-
26Jul
Patients with acute physical rehabilitation needs now can undergo inpatient treatment close to home thanks to a new partnership between Adventist Hinsdale Hospital and Marianjoy Rehabilitation Hospital. Announced today, the cooperative effort unites two organizations with similar holistic approaches to rehabilitative patient care for a variety of conditions in multiple settings.
-
23Jul
The appalling lack of access to scientifically proven interventions for key populations at risk — including sex workers, men who have sex with men and people who use drugs – and the lagging scale up of simple and inexpensive treatment regimens to prevent vertical transmission of HIV reflect persistent, underlying human rights violations that threaten future progress on AIDS, according to organizers of the XVIII International AIDS Conference taking place in Vienna this week under the theme of Rights Here, Right Now.
-
23Jul
Source: National Institute of Allergy and Infectious Diseases –
Related MedlinePlus Pages: AIDS and Infections, Tuberculosis -
22Jul
Johnson and Johnson’s experimental HIV drug rilpivirine or TMC278, a non-nucleoside reverse transcriptase inhibitor (NNRTI), is being developed for use in combination therapy for treating the human immunodeficiency virus (HIV) that causes AIDS. Two clinical trials with the drug has shown that although its effectiveness was same as the existing anti-HIV drugs, its side effects were fewer. On the flip side nearly twice as many patients failed to respond to treatment with the new drug.
-
22Jul
Tibotec Pharmaceuticals announced today results from two pivotal Phase 3, double-blind, randomized clinical trials comparing the efficacy, safety and tolerability of its investigational non-nucleoside reverse transcriptase inhibitor (NNRTI) TMC278 (rilpivirine) versus efavirenz (EFV), each administered once daily with a nucleoside/nucleotide background regimen in treatment-naive, HIV-1-infected adults.
-
22Jul
Source: HealthDay –
Related MedlinePlus Pages: Knee Injuries and Disorders, Sports Injuries, Surgery -
22Jul
As both cost containment of care and services and treatment-as-prevention gain greater prominence in the global fight against HIV/AIDS during the Vienna AIDS Conference, AIDS Healthcare Foundation (AHF), which currently provides AIDS medical care to more than 139,000 individuals in 23 countries worldwide, will host a satellite session today, July 21st, titled “Test and Treat: Getting to 10 Million on ARVs” (IAC Mini Room #5 at 6:30pm) preceded by a press conference (5pm, Media Center, Room PCR #2).
-
21Jul
The Methodist Hospital is the first in the U.S. to use a portable heart/lung machine to move critically ill patients easily and safely to different areas of the hospital for medical tests or from outlying hospitals to the medical center for specialized treatment. Recently approved for use in the U.S. by the FDA, the device has been used in Europe since 2008 with excellent results. “With this new device, we will never have to say that a patient is too sick to move,” said Dr. Matthias Loebe, transplant surgeon at The Methodist Hospital…
-
21Jul
Sweating can be a problem and a source of embarrassment. Here are ways to cope with heavy sweating at the gym, on the job, and everywhere you go.
Tags: Treatment
-
21Jul
To sweat is natural and healthy. Sweat helps cool the body. But excessive sweating can pose problems.
-
20Jul
More than 80% of children who are diagnosed with attention deficit hyperactivity disorder take prescription medications at some point to treat their symptoms, according to a new nationwide survey of parents by Consumer Reports Health.
-
20Jul
BD Biosciences, a segment of BD (Becton, Dickinson and Company), announced the creation of new dried reagents developed through a collaboration with ReaMetrix, a private biotechnology company based in Bangalore, India. The new reagents, expected to be available in 2011, are developed for the BD FACSCount™ Flow Cytometry System, which is recognized as the system of choice for CD4 monitoring in global HIV/AIDS treatment programs because of its simplicity, robust performance and reliability…
-
20Jul
MDMA (-3,4-methylenedioxymethamphetamine, also known as Ecstasy), may one day offer hope for individuals with posttraumatic stress disorder (PTSD), even people for whom other treatments have failed. Clinical trial results out today in the Journal of Psychopharmacology, published by SAGE, suggests that MDMA can be administered to subjects with PTSD without evidence of harm and could offer sufferers a vital window with reduced fear responses where psychotherapy can take effect.
-
19Jul
The World Health Organization suggests that treating people with HIV earlier could save lives and help them stay healthy for longer, while at the same saving money; the organization also estimates that a record 5.2 million people worldwide were receiving life-saving HIV treatment at the end of 2009, compared with 4 million a year earlier…
-
17Jul
The Gerontological Society of America (GSA) – the nation’s largest interdisciplinary organization devoted to the field of aging – has chosen Karl Pillemer, PhD, of Cornell University as the 2010 recipient of the M. Powell Lawton Award. This distinguished honor recognizes a significant contribution in gerontology that has led to an innovation in gerontological treatment, practice or service, prevention, amelioration of symptoms or barriers, or a public policy change that has led to some practical application that improves the lives of older persons…
-
17Jul
When you’re being treated for osteoporosis, a blood or urine test will provide clues or “markers” as to the progress of your treatments. But, it is important to realize that markers alone cannot indicate whether or not a treatment is working.
Tags: Treatment
Recent Comments